vs

Side-by-side financial comparison of BATTALION OIL CORP (BATL) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $31.6M, roughly 1.4× BATTALION OIL CORP). BATTALION OIL CORP runs the higher net margin — 5.7% vs -90.4%, a 96.1% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs -36.1%). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs -20.1%).

Battalion Oil Corp is an independent energy company engaged in the exploration, development, and production of crude oil, natural gas, and natural gas liquids. It primarily operates assets in the Eagle Ford Shale region of South Texas, serving commercial and industrial clients across North American energy markets.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

BATL vs PACB — Head-to-Head

Bigger by revenue
PACB
PACB
1.4× larger
PACB
$44.6M
$31.6M
BATL
Growing faster (revenue YoY)
PACB
PACB
+50.0% gap
PACB
13.8%
-36.1%
BATL
Higher net margin
BATL
BATL
96.1% more per $
BATL
5.7%
-90.4%
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
-20.1%
BATL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BATL
BATL
PACB
PACB
Revenue
$31.6M
$44.6M
Net Profit
$1.8M
$-40.4M
Gross Margin
37.1%
Operating Margin
-33.8%
-92.3%
Net Margin
5.7%
-90.4%
Revenue YoY
-36.1%
13.8%
Net Profit YoY
108.1%
-1802.7%
EPS (diluted)
$-0.77
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BATL
BATL
PACB
PACB
Q4 25
$31.6M
$44.6M
Q3 25
$43.4M
$38.4M
Q2 25
$42.6M
$39.8M
Q1 25
$47.4M
$37.2M
Q4 24
$49.5M
$39.2M
Q3 24
$45.1M
$40.0M
Q2 24
$49.1M
$36.0M
Q1 24
$49.5M
$38.8M
Net Profit
BATL
BATL
PACB
PACB
Q4 25
$1.8M
$-40.4M
Q3 25
$-735.0K
$-38.0M
Q2 25
$4.8M
$-41.9M
Q1 25
$6.0M
$-426.1M
Q4 24
$-22.2M
$2.4M
Q3 24
$21.6M
$-60.7M
Q2 24
$-105.0K
$-173.3M
Q1 24
$-31.2M
$-78.2M
Gross Margin
BATL
BATL
PACB
PACB
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
BATL
BATL
PACB
PACB
Q4 25
-33.8%
-92.3%
Q3 25
1.9%
-101.1%
Q2 25
-0.4%
-112.8%
Q1 25
7.2%
-1154.5%
Q4 24
-36.2%
-390.1%
Q3 24
2.3%
-160.3%
Q2 24
10.4%
-488.3%
Q1 24
0.0%
-209.6%
Net Margin
BATL
BATL
PACB
PACB
Q4 25
5.7%
-90.4%
Q3 25
-1.7%
-98.9%
Q2 25
11.3%
-105.4%
Q1 25
12.7%
-1146.8%
Q4 24
-44.9%
6.0%
Q3 24
48.0%
-151.9%
Q2 24
-0.2%
-481.3%
Q1 24
-63.0%
-201.4%
EPS (diluted)
BATL
BATL
PACB
PACB
Q4 25
$-0.77
$-0.11
Q3 25
$-0.91
$-0.13
Q2 25
$-0.21
$-0.14
Q1 25
$-0.35
$-1.44
Q4 24
$-1.47
$-0.44
Q3 24
$0.34
$-0.22
Q2 24
$-0.53
$-0.64
Q1 24
$-2.24
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BATL
BATL
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$28.0M
$279.5M
Total DebtLower is stronger
$208.1M
Stockholders' EquityBook value
$-32.8M
$5.3M
Total Assets
$460.7M
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BATL
BATL
PACB
PACB
Q4 25
$28.0M
$279.5M
Q3 25
$50.5M
$298.7M
Q2 25
$44.6M
$314.7M
Q1 25
$73.6M
$343.1M
Q4 24
$19.7M
$389.9M
Q3 24
$29.8M
$471.1M
Q2 24
$54.4M
$509.8M
Q1 24
$48.9M
$561.9M
Total Debt
BATL
BATL
PACB
PACB
Q4 25
$208.1M
Q3 25
$213.8M
Q2 25
$219.4M
Q1 25
$225.1M
Q4 24
$162.1M
Q3 24
$147.8M
Q2 24
$160.4M
Q1 24
$190.2M
Stockholders' Equity
BATL
BATL
PACB
PACB
Q4 25
$-32.8M
$5.3M
Q3 25
$-20.3M
$36.1M
Q2 25
$-5.2M
$61.5M
Q1 25
$-1.8M
$91.6M
Q4 24
$4.1M
$506.6M
Q3 24
$35.0M
$453.1M
Q2 24
$22.7M
$492.7M
Q1 24
$31.3M
$649.0M
Total Assets
BATL
BATL
PACB
PACB
Q4 25
$460.7M
$784.1M
Q3 25
$491.7M
$803.2M
Q2 25
$498.8M
$825.5M
Q1 25
$506.2M
$860.8M
Q4 24
$431.0M
$1.3B
Q3 24
$458.0M
$1.5B
Q2 24
$487.3M
$1.5B
Q1 24
$488.6M
$1.7B
Debt / Equity
BATL
BATL
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
39.35×
Q3 24
4.23×
Q2 24
7.07×
Q1 24
6.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BATL
BATL
PACB
PACB
Operating Cash FlowLast quarter
$-11.8M
$-19.1M
Free Cash FlowOCF − Capex
$-19.9M
FCF MarginFCF / Revenue
-44.6%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
-6.58×
TTM Free Cash FlowTrailing 4 quarters
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BATL
BATL
PACB
PACB
Q4 25
$-11.8M
$-19.1M
Q3 25
$28.0M
$-18.7M
Q2 25
$10.2M
$-29.4M
Q1 25
$12.7M
$-44.1M
Q4 24
$6.7M
$-30.6M
Q3 24
$-5.1M
$-45.5M
Q2 24
$29.8M
$-54.3M
Q1 24
$3.9M
$-75.7M
Free Cash Flow
BATL
BATL
PACB
PACB
Q4 25
$-19.9M
Q3 25
$-18.8M
Q2 25
$-29.9M
Q1 25
$-45.4M
Q4 24
$-32.3M
Q3 24
$-46.3M
Q2 24
$-55.7M
Q1 24
$-79.6M
FCF Margin
BATL
BATL
PACB
PACB
Q4 25
-44.6%
Q3 25
-48.9%
Q2 25
-75.3%
Q1 25
-122.3%
Q4 24
-82.3%
Q3 24
-115.7%
Q2 24
-154.8%
Q1 24
-205.0%
Capex Intensity
BATL
BATL
PACB
PACB
Q4 25
1.9%
Q3 25
0.2%
Q2 25
1.4%
Q1 25
3.7%
Q4 24
4.1%
Q3 24
2.0%
Q2 24
4.1%
Q1 24
10.0%
Cash Conversion
BATL
BATL
PACB
PACB
Q4 25
-6.58×
Q3 25
Q2 25
2.13×
Q1 25
2.11×
Q4 24
-12.93×
Q3 24
-0.23×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BATL
BATL

Oil$28.6M91%
Natural Gas Liquids Reserves$3.9M12%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons